Varian Medical Systems to Highlight Trilogy™, A Powerful New Product for Robotic Non-Invasive Neurosurgery, at the Congress of Neurological Surgeons Annual Meeting | Varian

Varian Medical Systems to Highlight Trilogy™, A Powerful New Product for Robotic Non-Invasive Neurosurgery, at the Congress of Neurological Surgeons Annual Meeting

PALO ALTO, Calif., Oct. 7 /PRNewswire-FirstCall/ -- Varian Medical Systems (NYSE: VAR) will feature the newest, most advanced imaging and treatment technologies for image-guided non-invasive neurosurgery at the upcoming annual meeting of the Congress of Neurological Surgeons (CNS) from October 8-13 at the John B. Hynes Veterans Memorial Convention Center in Boston, Massachusetts.

"We are offering a clinically advanced and cost-efficient alternative to single-purpose radiosurgical devices that are limited in functionality and flexibility," said Lester Boeh, vice president for Varian Medical Systems and general manager of Varian Surgical Sciences. "The Trilogy system can be used for non-invasive, painless, neurosurgical treatments of tumors, vascular malformation, and other neurological abnormalities."

The Trilogy Stereotactic System, introduced in 2004, makes it possible to treat small areas in the brain and other parts of the body rapidly, with powerful, precisely placed beams. "This is the most powerful, precise, and versatile treatment solution ever developed, and it represents the future for patient treatment delivery, improving the quality of care while increasing efficiency and lowering the cost of treatment," Boeh said.

Shands HealthCare at the University of Florida in Gainesville -- a notable neurosurgery treatment site -- recently ordered the Trilogy System for image-guided neurosurgery. According to Frank J. Bova, PhD, professor of neurological surgery at the University of Florida, his team chose the Trilogy system because it is "a single therapeutic tool that exceeds the capabilities of all other radiosurgery devices on the market. The high accuracy and guidance systems make it possible for us to deliver intra and extra-cranial treatments using a single integrated unit. Varian has provided the radiosurgery team with unprecedented access to the fullest complement of radiosurgery tools commercially available."

In addition to the Trilogy Stereotactic System, Varian will be exhibiting an assortment of hardware and software products for the neurosurgery market, including:

-- Patient immobilization and motion management devices for stereotactic
   -- The SonArray 3-D ultrasound patient positioning system
   -- Treatment planning software for stereotactic radiosurgery

High resolution images of the Trilogy Stereotactic System are available in the image gallery at Varian's online newsroom: .


Varian Medical Systems, Inc., of Palo Alto, California is the world's leading manufacturer of integrated radiotherapy and neurosurgery systems, which are treating thousands of patients per day. The company is also a premier supplier of X-ray tubes and flat-panel digital subsystems for imaging in medical, scientific, and industrial applications. Varian Medical Systems employs approximately 3,280 people who are located at manufacturing sites in North America and Europe and in its 56 sales and support offices around the world. Additional information is available on the company's web site at .


Statements in this press release regarding future business, events, plans, objectives, expectations, estimates, and other similar matters, including, but not limited to, statements using the terms "will," "can," and "possible" constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements contained in this press release are subject to risks and uncertainties that could cause actual results to differ materially from those anticipated, including, but not limited to, the risks described in the company's Annual Report on Form 10-K and other reports filed from time to time by the Company with the Securities and Exchange Commission. These forward-looking statements represent the Company's judgment as of the date of this press release. The Company assumes no obligation to update or revise these forward-looking statements because of new information, future events, or otherwise.

   Spencer Sias, (650) 424-5782

   Meryl Ginsberg, (650) 424-6444

   CNS Booth #2232

SOURCE: Varian Medical Systems, Inc.

Web site: